Atlas Trials

A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

Clinical trial NCT04269395 · TERMINATED

Trial details

NCT number
NCT04269395
Sponsor
Galderma R&D
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Keratosis, Actinic
Start date
2020-04-07
Primary completion
2021-09-01
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.